Randomized Phase 2 Study Comparing Pathological Responses of Resected Colorectal Cancer Metastases after Bevacizumab with mFOLFOX6 or FOLFIRI (BEV-ONCO Trial).
Baldin P, Carrasco J, Beniuga G, Jouret-Mourin A, Demolin G, Roland S, D'Hondt L, Vergauwe P, Van Daele D, Mailleux M, Sinapi I, De Cuyper A, Blétard N, Massart B, Delos M, Castella ML, van Maanen A, Van den Eynde M.
Baldin P, et al. Among authors: roland s.
Cancers (Basel). 2022 Feb 24;14(5):1183. doi: 10.3390/cancers14051183.
Cancers (Basel). 2022.
PMID: 35267491
Free PMC article.